Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type
NCT01479855 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2013-11-27
Summary
The purpose of the study is to compare the concentrations of Vitamin B1 (thiamine), Vitamin B6 (pyridoxal-5-phosphate), folate, Vitamin B12 (cobalamin), Vitamin C (ascorbic acid), Vitamin A (retinol), Vitamin E (alfa-tocopherol), homocystein, uric acid, F2 8-α-isoprostane, 8-deoxyguanosine, retinoids, tau-protein and β-amyloid in spinal fluid, metabolomics, proteomics, m-RNA for DNA repair enzymes and DNA in patients who suffer from mild cognitive impairment (MCI) or mild dementia of Alzheimers type, with healthy controls.
A second aim is to explore the association between vitamin and nutrient reductions, if any, and cognitive function as well as vascular score and possible changes in the MRI.
Conditions
- Mild Cognitive Impairment
- Alzheimers Disease
Sponsors & Collaborators
-
South Eastern Area Health Service
collaborator OTHER -
Oslo University Hospital
lead OTHER
Principal Investigators
-
Ingun D Ulstein, MD PhD · Oslo University Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- Norway
Study Locations
More Related Trials
-
Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia
NCT04430517 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases
NCT02288000 ·Status: TERMINATED ·Phase: PHASE1
-
Polyamine-enriched Diet in Elderly Individuals With Subjective Cognitive Decline
NCT03094546 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease
NCT00013923 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease
NCT00235716 ·Status: COMPLETED ·Phase: PHASE3
-
An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian Population
NCT02249468 ·Status: TERMINATED
-
Influence of Oxidative Stress and Nutrition Biomarkers on the Cognitive Decline Evolution in Alzheimer Disease
NCT02800395 ·Status: RECRUITING ·Phase: NA
-
Double Blind Study of Trp01 in Patients With Alzheimer's Disease
NCT00202124 ·Status: COMPLETED ·Phase: PHASE4
-
The Use of Memantine for Prevention of Alzheimer's Disease
NCT05063851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Enhancing Health and Quality of Life for Individuals With Dementia Through Transitional-State Snacks
NCT05007730 ·Status: COMPLETED ·Phase: NA
-
Vitamin B12 Supplement to Prevent Cognitive Decline
NCT02457507 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients
NCT00255086 ·Status: COMPLETED ·Phase: PHASE3
-
Statins, Cholesterol and Cognitive Decline in Alzheimer's
NCT06635252 ·Status: COMPLETED
-
A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355
NCT03802162 ·Status: COMPLETED ·Phase: PHASE1
-
Hyperhomocysteinemia in Alzheimer's Disease
NCT05793372 ·Status: NOT_YET_RECRUITING
-
Novel Diagnostic and Disease Stage Biomarkers in AD
NCT05175664 ·Status: COMPLETED
-
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
NCT03703856 ·Status: COMPLETED ·Phase: PHASE4
-
TRx0014 in Patients With Mild or Moderate Alzheimer's Disease
NCT00515333 ·Status: COMPLETED ·Phase: PHASE2
-
Dementias and Microbiota Composition: Is Possible to Revert the Dementia Symptoms Reverting the Microbiota Composition?
NCT05943925 ·Status: UNKNOWN
-
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
NCT03019757 ·Status: RECRUITING
-
Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy Volunteers
NCT01461174 ·Status: COMPLETED ·Phase: PHASE1
-
Alzheimer's Disease: Potential Benefit of Isoflavones
NCT00205179 ·Status: COMPLETED ·Phase: PHASE2
-
Influence of Luteolin for Two Weeks on Memory in Healthy Subjects
NCT06047899 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
NCT01689246 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of a Nutraceutic Compound on Cognitive Impairment
NCT06200883 ·Status: COMPLETED ·Phase: PHASE4